title: Psychopharmacologic treatment of dissociative fugue and PTSD in an Ethiopian refugee.
abstract: Despite widespread awareness of their frequent co-occurrence, little is known about treatment of individuals with comorbid posttraumatic stress disorder (PTSD) and dissociative disorders. Patients with dissociative disorders do not respond well to standard exposure therapy, and few psychopharmacologic trials exist. Fluoxetine proved ineffective for depersonalization disorder, but paroxetine showed efficacy in decreasing dissociative symptoms in PTSD patients.
authors.affiliation: Neighborhood Healthcare, 855 E Madison Ave, El Cajon, CA 92020 DorothyLiu1@gmail.com.
authors.forename: Dorothy
authors.initials: D
authors.lastname: Liu-Barbaro
authors.forename: Murray
authors.initials: M
authors.lastname: Stein
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D015897:Comorbidity; D004213:Dissociative Disorders / Q000175:diagnosis / Q000188:drug therapy*; D005002:Ethiopia; D006801:Humans; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000008:administration & dosage / Q000494:pharmacology; D012036:Refugees / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D020280:Sertraline / Q000008:administration & dosage / Q000494:pharmacology; D013313:Stress Disorders, Post-Traumatic / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D011224:Prazosin; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline